These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6986497)

  • 21. Specific induction of local antitumor effector cells mediated in vivo by the circulating lymphocyte pool.
    Crum ED
    Cancer Res; 1987 Nov; 47(21):5584-9. PubMed ID: 3311355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inability of antiserum active in antibody-dependent cellular cytotoxicity and arming tests to protect against simian virus 40 tumor cell challenge.
    Prather SO; Geller RW; Lausch RN
    J Natl Cancer Inst; 1979 May; 62(5):1273-7. PubMed ID: 220449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective serum effects in tumor immunity.
    Vaage J
    Isr J Med Sci; 1976; 12(4-5):334-43. PubMed ID: 939693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mode of action of polyethylene glycol 6000 in potentiating the in vitro generation of antitumor cytotoxicity by MOPC-315 tumor bearer spleen cells.
    Mokyr MB; Przepiorka D; Dray S
    Cancer Res; 1982 Jul; 42(7):2537-43. PubMed ID: 6805940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of tumor incidence by oncofetal products in a syngeneic hepatoma cell-spleen cell model.
    Mizejewski GJ; Macario AL
    Neoplasma; 1983; 30(1):23-34. PubMed ID: 6188067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific cytostatic effect of lymph node cells from normal and T cell-deficient mice on syngeneic tumor target cells in vitro and its specific abrogation by body fluids from syngeneic tumor-bearing mice.
    Chia E; Festenstein H
    Eur J Immunol; 1973 Aug; 3(8):483-7. PubMed ID: 4543175
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of a growing tumor and its removal on the cytotoxicity of macrophages from cultured bone marrow cells.
    Fisher B; Wolmark N; Coyle J; Saffer EA
    Cancer Res; 1976 Jul; 36(7 PT 1):2302-5. PubMed ID: 1277133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of suppressor lymphocytes during sensitization in culture against a syngeneic tumor: affinity chromatography on insolubilized histamine.
    Schechter B; Segal S; Feldman M
    J Immunol; 1978 Apr; 120(4):1268-73. PubMed ID: 641348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogeneic bone marrow donors with a recipient-derived tumor cell vaccine.
    Anderson LD; Petropoulos D; Everse LA; Mullen CA
    Cancer Res; 1999 Apr; 59(7):1525-30. PubMed ID: 10197624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ambiguous action of splenocytes from tumor-bearing mice on the formation of metastases in the lungs of mice in an adaptive transfer system].
    Iunker VM; Arkhipov SA; Gruntenko EV
    Biull Eksp Biol Med; 1984 Nov; 98(11):598-600. PubMed ID: 6509179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. K-cell cytotoxic activity in the spleen and lymph nodes of tumour-bearing mice.
    Calder EA; Irvine WJ; Ghaffer A
    Clin Exp Immunol; 1975 Feb; 19(2):393-7. PubMed ID: 1212806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in the mitogen response of lymphoid cells with progressive tumor growth.
    Gillette RW; Boone CW
    Cancer Res; 1975 Dec; 35(12):3774-9. PubMed ID: 1081429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Augmentation of the anti-tumor activity of regional lymph node lymphocytes and spleen cells of tumor-bearing mice by culture with T cell growth factor in vitro--a comparison of the intestinal cancer model and footpad cancer model].
    Hori T; Kan N; Inamoto T; Nio Y; Ohgaki K; Kodama H; Tobe T
    Nihon Geka Gakkai Zasshi; 1986 Mar; 87(3):287-96. PubMed ID: 3487027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition by lymphoid cellular factors of the immunological cytotoxicity against a syngeneic tumour.
    Lafontaine N; Firket H
    Pathol Eur; 1976; 11(2):147-50. PubMed ID: 958732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of tumor growth on migratory properties of T lymphocytes in rats.
    Klobusická M; Koníková E; Novotná L
    Neoplasma; 1980; 27(6):675-82. PubMed ID: 6973097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapy of leukemia by nonimmune syngeneic spleen cells.
    Cheever MA; Greenberg PD; Fefer A
    J Immunol; 1980 May; 124(5):2137-42. PubMed ID: 7365249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lectin-dependent cell-mediated cytotoxicity: assessment of cytotoxic reactivity following challenge with syngeneic tumors.
    Laux DC; Parker BM; DiSciullo SO; Petrarca MA; McAllister CG
    J Natl Cancer Inst; 1984 Mar; 72(3):667-72. PubMed ID: 6583449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune response of mice to sarcoma I allograft studied by adoptive transfers of spleen, thymus, and lymph node cells to secondary recipients.
    Vidrnová M; Nouza K; Panajotovová V
    Neoplasma; 1985; 32(4):451-61. PubMed ID: 4047256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenoviral gene transfer of stromal cell-derived factor-1 to murine tumors induces the accumulation of dendritic cells and suppresses tumor growth.
    Fushimi T; O'Connor TP; Crystal RG
    Cancer Res; 2006 Apr; 66(7):3513-22. PubMed ID: 16585175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.